The ‘thorough QT/QTc study’ has a critical role in evaluating QT/QTc interval prolongation of a drug. In designing the ‘thorough QT/QTc study' it is important to consider cause of variation of QT intervals and risk factors of QT prolongation, such as reliability of QT interval measurement, diurnal variation, pharmacokinetics, pharmacokinetics-pharmacodynamics relationship, age, gender, electrolyte abnormalities, concomitant drugs, concomitant diseases, etc. Choice of parallel or cross-over design and sample size determination are also discussed.
抄録全体を表示